• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在抗肺炎球菌血清中存在非同源特异性可溶性物质中和的特异性保护抗体。

ON THE PRESENCE IN ANTIPNEUMOCOCCUS SERUM OF TYPE-SPECIFIC PROTECTIVE ANTIBODY NOT NEUTRALIZED BY HOMOLOGOUS SPECIFIC SOLUBLE SUBSTANCE.

机构信息

Department of Bacteriology and Immunology, New York University and Bellevue Hospital Medical College, New York.

出版信息

J Exp Med. 1931 Jan 1;53(1):93-107. doi: 10.1084/jem.53.1.93.

DOI:10.1084/jem.53.1.93
PMID:19869830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2131943/
Abstract

The mutual relationship of the anticarbohydrate precipitins and the protective action in antipneumococcus sera to the soluble specific substance was investigated. The assumption is made that there exists in antipneumococcus serum, type-specific protective antibody which is distinct from the anticarbohydrate precipitins and is not neutralized by the soluble specific substance. This assumption is based upon the following observations in experiments which were conducted primarily with Type I antipneumococcus horse serum. 1. Lack of proportionality between the quantity of SSS added and the amount of anticarbohydrate precipitin and protective action neutralized. 2. Protective capacity of specific precipitates (SSS-precipitin complex) is accounted for on the basis of a liberation of non-specifically adsorbed protective antibody. 3. SSS only partially neutralizes the protective action of antipneumococcus serum in vivo. 4. Type-specific protective antibody remains in antipneumococcus serum after complete precipitation of the anticarbohydrate precipitins. 5. This residual type-specific protective antibody is not neutralized by additional SSS nor by absorption with heterologous pneumococci; it is definitely absorbed by the homologous pneumococci.

摘要

研究了抗碳水化合物沉淀素与抗肺炎球菌血清中的保护性作用与可溶性特异物质之间的相互关系。假设抗肺炎球菌血清中存在与抗碳水化合物沉淀素不同的、针对特定类型的保护性抗体,并且不受可溶性特异物质的中和。这一假设基于以下观察结果:在主要针对 I 型肺炎球菌马血清进行的实验中:1. 添加 SSS 的量与中和的抗碳水化合物沉淀素和保护作用之间缺乏比例关系。2. 特异性沉淀物(SSS-沉淀素复合物)的保护能力是基于非特异性吸附的保护性抗体的释放来解释的。3. SSS 仅部分中和肺炎球菌血清在体内的保护作用。4. 碳水化合物沉淀素完全沉淀后,抗肺炎球菌血清中仍存在针对特定类型的保护性抗体。5. 这种残留的针对特定类型的保护性抗体不受额外的 SSS 中和,也不被吸收异源肺炎球菌吸收;它肯定被同源肺炎球菌吸收。

相似文献

1
ON THE PRESENCE IN ANTIPNEUMOCOCCUS SERUM OF TYPE-SPECIFIC PROTECTIVE ANTIBODY NOT NEUTRALIZED BY HOMOLOGOUS SPECIFIC SOLUBLE SUBSTANCE.在抗肺炎球菌血清中存在非同源特异性可溶性物质中和的特异性保护抗体。
J Exp Med. 1931 Jan 1;53(1):93-107. doi: 10.1084/jem.53.1.93.
2
PROPERTIES OF THE TYPE SPECIFIC PROTEINS OF ANTIPNEUMOCOCCUS SERA : II. IMMUNOLOGICAL FRACTIONATION OF TYPE I ANTIPNEUMOCOCCUS HORSE AND RABBIT SERA.抗肺炎球菌血清的特异性蛋白质特性:II. Ⅰ型抗肺炎球菌马和兔血清的免疫学分离。
J Exp Med. 1937 Sep 30;66(4):425-35. doi: 10.1084/jem.66.4.425.
3
A STUDY OF PNEUMOCOCCI REACTING WITH ANTIPNEUMOCOCCUS SERA OF TYPES I, II, AND III, WITH AN OBSERVATION OF A MUTATION OF ONE OF THE STRAINS.Ⅰ、Ⅱ、Ⅲ型肺炎球菌与抗肺炎球菌血清反应的研究,以及一株菌的突变观察。
J Exp Med. 1919 Aug 1;30(2):123-46. doi: 10.1084/jem.30.2.123.
4
THE IMMUNOLOGICAL RELATIONSHIP OF THE CAPSULAR POLYSACCHARIDE OF TYPE XIV PNEUMOCOCCUS TO THE BLOOD GROUP A SPECIFIC SUBSTANCE.第十四型肺炎球菌荚膜多糖与 A 血型特异性物质的免疫学关系。
J Exp Med. 1939 Aug 31;70(3):239-47. doi: 10.1084/jem.70.3.239.
5
THE ANTIPNEUMOCOCCUS PROPERTIES OF NORMAL SWINE SERUM.正常猪血清的抗肺炎球菌特性。
J Exp Med. 1932 May 31;55(6):877-88. doi: 10.1084/jem.55.6.877.
6
AN EXAMINATION OF THE MECHANISM OF PNEUMOCOCCUS IMMUNITY BY MEANS OF BACTERICIDAL MEASUREMENTS : I. THE REACTION BETWEEN THE ANTICARBOHYDRATE ANTIBODY AND THE PURIFIED SPECIFIC CARBOHYDRATE.肺炎球菌免疫机制的研究:一、抗碳水化合物抗体与纯化特异性碳水化合物的反应。
J Exp Med. 1932 Mar 31;55(4):511-8. doi: 10.1084/jem.55.4.511.
7
THE PROTECTIVE ACTION OF TYPE I ANTIPNEUMOCOCCUS SERUM IN MICE : IV. THE PROZONE.I 型抗肺炎球菌血清对小鼠的保护作用:IV. 前区带。
J Exp Med. 1936 Aug 31;64(3):369-75. doi: 10.1084/jem.64.3.369.
8
PROPERTIES OF THE TYPE SPECIFIC PROTEINS OF ANTIPNEUMOCOCCUS SERA : I. THE MOUSE PROTECTIVE VALUE OF TYPE I SERA WITH REFERENCE TO THE PRECIPITIN CONTENT.抗肺炎球菌血清的特异性蛋白质的特性:I. 关于沉淀素含量的 I 型血清的小鼠保护价值。
J Exp Med. 1937 Sep 30;66(4):413-24. doi: 10.1084/jem.66.4.413.
9
QUANTITATIVE EXPERIMENTS WITH ANTIBODIES TO A SPECIFIC PRECIPITATE. I.抗特定沉淀素的定量实验。一。
J Exp Med. 1941 Jan 1;73(1):125-40. doi: 10.1084/jem.73.1.125.
10
THE CONCENTRATION OF THE PROTECTIVE BODIES IN ANTIPNEUMOCOCCUS SERUM. SPECIFIC PRECIPITATE EXTRACTS.抗肺炎球菌血清中保护性抗体的浓度。特异性沉淀提取物。
J Exp Med. 1915 Aug 1;22(2):248-68. doi: 10.1084/jem.22.2.248.

引用本文的文献

1
THE IMMUNOLOGICAL RELATIONSHIP OF THE CAPSULAR POLYSACCHARIDE OF TYPE XIV PNEUMOCOCCUS TO THE BLOOD GROUP A SPECIFIC SUBSTANCE.第十四型肺炎球菌荚膜多糖与 A 血型特异性物质的免疫学关系。
J Exp Med. 1939 Aug 31;70(3):239-47. doi: 10.1084/jem.70.3.239.
2
ON THE USE OF ADSORBENTS IN IMMUNIZATIONS WITH HAPTENS.关于半抗原免疫中吸附剂的应用。
J Exp Med. 1934 Mar 31;59(4):479-90. doi: 10.1084/jem.59.4.479.
3
CHEMOIMMUNOLOGICAL STUDIES ON THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : I. THE ISOLATION AND PROPERTIES OF THE ACETYL POLYSACCHARIDE OF PNEUMOCOCCUS TYPE I.肺炎球菌可溶性特异物质的化学免疫学研究:I. 肺炎球菌 I 型乙酰多糖的分离与特性。
J Exp Med. 1933 Nov 30;58(6):731-55. doi: 10.1084/jem.58.6.731.
4
THE PRECIPITIN REACTION OF ANTIPNEUMOCOCCUS SERA : III. THE RATIO OF PRECIPITIN TO PROTECTIVE ANTIBODY IN TYPE II.抗肺炎球菌血清沉淀反应:III. Ⅱ型中沉淀素与保护性抗体的比例。
J Exp Med. 1931 Feb 28;53(3):299-301. doi: 10.1084/jem.53.3.299.
5
Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae.针对蛋白酶敏感的肺炎球菌抗原的单克隆抗体可保护小鼠免受肺炎链球菌的致命感染。
J Exp Med. 1984 Aug 1;160(2):386-97. doi: 10.1084/jem.160.2.386.
6
Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).利用插入失活来促进对肺炎球菌表面蛋白A(PspA)生物学特性的研究。
J Exp Med. 1987 Feb 1;165(2):381-94. doi: 10.1084/jem.165.2.381.

本文引用的文献

1
A TYPE SPECIFIC SUBSTANCE DISTINCT FROM THE SPECIFIC CARBOHYDRATE IN PNEUMOCOCCUS TYPE I.一种与肺炎球菌型 I 中的特定碳水化合物不同的特异性物质。
J Exp Med. 1930 Jul 31;52(2):235-52. doi: 10.1084/jem.52.2.235.
2
A QUANTITATIVE STUDY OF THE PRECIPITIN REACTION BETWEEN TYPE III PNEUMOCOCCUS POLYSACCHARIDE AND PURIFIED HOMOLOGOUS ANTIBODY.Ⅲ型肺炎球菌多糖与纯化同源抗体沉淀反应的定量研究。
J Exp Med. 1929 Nov 30;50(6):809-23. doi: 10.1084/jem.50.6.809.
3
IMMUNOLOGICAL PROPERTIES OF A TYPICAL (S-PRODUCING) AND A DEGRADED (NON-S-PRODUCING) STRAIN OF TYPE II PNEUMOCOCCUS WITH SPECIAL REFERENCE TO PROTECTIVE ANTIBODIES.Ⅱ型肺炎球菌典型(S 型产生)和退化(非 S 型产生)菌株的免疫学特性,特别提到保护性抗体。
J Exp Med. 1927 Jun 30;46(1):101-11. doi: 10.1084/jem.46.1.101.
4
STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : VI. THE SPECIFIC EFFECT OF PNEUMOCOCCUS SOLUBLE SUBSTANCE ON THE GROWTH OF PNEUMOCOCCI IN NORMAL SERUM-LEUCOCYTE MIXTURES.肺炎球菌生长抑制的研究:六、肺炎球菌可溶性物质对正常血清-白细胞混合物中肺炎球菌生长的特异性影响。
J Exp Med. 1926 Apr 30;43(5):633-45. doi: 10.1084/jem.43.5.633.
5
THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : THIRD PAPER.肺炎球菌可溶性特异性物质:第三报。
J Exp Med. 1925 Oct 31;42(5):727-45. doi: 10.1084/jem.42.5.727.
6
THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH.肺炎球菌生长过程中特定可溶性物质的形成。
J Exp Med. 1917 Oct 1;26(4):477-93. doi: 10.1084/jem.26.4.477.
7
THE NEUTRALIZATION OF ANTIPNEUMOCOCCUS IMMUNE BODIES BY INFECTED EXUDATES AND SERA.感染渗出物和血清对肺炎球菌免疫抗体的中和作用。
J Exp Med. 1917 Oct 1;26(4):453-75. doi: 10.1084/jem.26.4.453.
8
CONCENTRATION OF THE PROTECTIVE BODIES IN ANTIPNEUMOCOCCUS SERUM BY MEANS OF SPECIFIC PRECIPITATION.抗肺炎球菌血清中保护性抗体的浓度通过特异性沉淀来测定。
J Exp Med. 1915 Apr 1;21(4):389-400. doi: 10.1084/jem.21.4.389.